These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 31949011)

  • 1. Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party.
    Henes J; Oliveira MC; Labopin M; Badoglio M; Scherer HU; Del Papa N; Daikeler T; Schmalzing M; Schroers R; Martin T; Pugnet G; Simoes B; Michonneau D; Marijt EWA; Lioure B; Olivier Bay J; Snowden JA; Rovira M; Huynh A; Onida F; Kanz L; Marjanovic Z; Farge D
    Haematologica; 2021 Feb; 106(2):375-383. PubMed ID: 31949011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis.
    Burt RK; Oliveira MC; Shah SJ; Moraes DA; Simoes B; Gheorghiade M; Schroeder J; Ruderman E; Farge D; Chai ZJ; Marjanovic Z; Jain S; Morgan A; Milanetti F; Han X; Jovanovic B; Helenowski IB; Voltarelli J
    Lancet; 2013 Mar; 381(9872):1116-24. PubMed ID: 23363664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.
    Sullivan KM; Goldmuntz EA; Keyes-Elstein L; McSweeney PA; Pinckney A; Welch B; Mayes MD; Nash RA; Crofford LJ; Eggleston B; Castina S; Griffith LM; Goldstein JS; Wallace D; Craciunescu O; Khanna D; Folz RJ; Goldin J; St Clair EW; Seibold JR; Phillips K; Mineishi S; Simms RW; Ballen K; Wener MH; Georges GE; Heimfeld S; Hosing C; Forman S; Kafaja S; Silver RM; Griffing L; Storek J; LeClercq S; Brasington R; Csuka ME; Bredeson C; Keever-Taylor C; Domsic RT; Kahaleh MB; Medsger T; Furst DE;
    N Engl J Med; 2018 Jan; 378(1):35-47. PubMed ID: 29298160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial.
    Burt RK; Shah SJ; Dill K; Grant T; Gheorghiade M; Schroeder J; Craig R; Hirano I; Marshall K; Ruderman E; Jovanovic B; Milanetti F; Jain S; Boyce K; Morgan A; Carr J; Barr W
    Lancet; 2011 Aug; 378(9790):498-506. PubMed ID: 21777972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease.
    Binks M; Passweg JR; Furst D; McSweeney P; Sullivan K; Besenthal C; Finke J; Peter HH; van Laar J; Breedveld FC; Fibbe WE; Farge D; Gluckman E; Locatelli F; Martini A; van den Hoogen F; van de Putte L; Schattenberg AV; Arnold R; Bacon PA; Emery P; Espigado I; Hertenstein B; Hiepe F; Kashyap A; Kötter I; Marmont A; Martinez A; Pascual MJ; Gratwohl A; Prentice HG; Black C; Tyndall A
    Ann Rheum Dis; 2001 Jun; 60(6):577-84. PubMed ID: 11350846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan.
    Ayano M; Tsukamoto H; Mitoma H; Kimoto Y; Akahoshi M; Arinobu Y; Miyamoto T; Horiuchi T; Niiro H; Nagafuji K; Harada M; Akashi K
    Arthritis Res Ther; 2019 Jan; 21(1):30. PubMed ID: 30670057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of autologous stem cell transplantation for systemic sclerosis -- a single-center longterm experience in 26 patients with severe organ manifestations.
    Henes JC; Schmalzing M; Vogel W; Riemekasten G; Fend F; Kanz L; Koetter I
    J Rheumatol; 2012 Feb; 39(2):269-75. PubMed ID: 22247352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis.
    Vonk MC; Marjanovic Z; van den Hoogen FH; Zohar S; Schattenberg AV; Fibbe WE; Larghero J; Gluckman E; Preijers FW; van Dijk AP; Bax JJ; Roblot P; van Riel PL; van Laar JM; Farge D
    Ann Rheum Dis; 2008 Jan; 67(1):98-104. PubMed ID: 17526554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow Transplantation.
    Sullivan KM; Majhail NS; Bredeson C; Carpenter PA; Chatterjee S; Crofford LJ; Georges GE; Nash RA; Pasquini MC; Sarantopoulos S; Storek J; Savani B; St Clair EW
    Biol Blood Marrow Transplant; 2018 Oct; 24(10):1961-1964. PubMed ID: 29953945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study.
    Farge D; Marolleau JP; Zohar S; Marjanovic Z; Cabane J; Mounier N; Hachulla E; Philippe P; Sibilia J; Rabian C; Chevret S; Gluckman E;
    Br J Haematol; 2002 Dec; 119(3):726-39. PubMed ID: 12437652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous stem cell transplantation in systemic sclerosis: a systematic review.
    Host L; Nikpour M; Calderone A; Cannell P; Roddy J
    Clin Exp Rheumatol; 2017; 35 Suppl 106(4):198-207. PubMed ID: 28869416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation.
    Burt RK; Traynor AE; Pope R; Schroeder J; Cohen B; Karlin KH; Lobeck L; Goolsby C; Rowlings P; Davis FA; Stefoski D; Terry C; Keever-Taylor C; Rosen S; Vesole D; Fishman M; Brush M; Mujias S; Villa M; Burns WH
    Blood; 1998 Nov; 92(10):3505-14. PubMed ID: 9808541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases.
    Farge D; Labopin M; Tyndall A; Fassas A; Mancardi GL; Van Laar J; Ouyang J; Kozak T; Moore J; Kötter I; Chesnel V; Marmont A; Gratwohl A; Saccardi R
    Haematologica; 2010 Feb; 95(2):284-92. PubMed ID: 19773265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis: results of a long-term follow-up multicentre study.
    van Bijnen S; de Vries-Bouwstra J; van den Ende CH; Boonstra M; Kroft L; Geurts B; Snoeren M; Schouffoer A; Spierings J; van Laar JM; Huizinga TW; Voskuyl A; Marijt E; van der Velden W; van den Hoogen FH; Vonk MC
    Ann Rheum Dis; 2020 Aug; 79(8):1084-1089. PubMed ID: 32409324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis.
    Oyama Y; Barr WG; Statkute L; Corbridge T; Gonda EA; Jovanovic B; Testori A; Burt RK
    Bone Marrow Transplant; 2007 Sep; 40(6):549-55. PubMed ID: 17646844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial.
    van Laar JM; Farge D; Sont JK; Naraghi K; Marjanovic Z; Larghero J; Schuerwegh AJ; Marijt EW; Vonk MC; Schattenberg AV; Matucci-Cerinic M; Voskuyl AE; van de Loosdrecht AA; Daikeler T; Kötter I; Schmalzing M; Martin T; Lioure B; Weiner SM; Kreuter A; Deligny C; Durand JM; Emery P; Machold KP; Sarrot-Reynauld F; Warnatz K; Adoue DF; Constans J; Tony HP; Del Papa N; Fassas A; Himsel A; Launay D; Lo Monaco A; Philippe P; Quéré I; Rich É; Westhovens R; Griffiths B; Saccardi R; van den Hoogen FH; Fibbe WE; Socié G; Gratwohl A; Tyndall A;
    JAMA; 2014 Jun; 311(24):2490-8. PubMed ID: 25058083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety profile of autologous hematopoietic stem cell mobilization and transplantation in patients with systemic sclerosis.
    Helbig G; Widuchowska M; Koclęga A; Kopińska A; Kopeć-Mędrek M; Gaweł WB; Spałek A; Żak J; Grygoruk-Wiśniowska I; Liwoch R; Kucharz E; Markiewicz M
    Clin Rheumatol; 2018 Jun; 37(6):1709-1714. PubMed ID: 29256111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes.
    McSweeney PA; Nash RA; Sullivan KM; Storek J; Crofford LJ; Dansey R; Mayes MD; McDonagh KT; Nelson JL; Gooley TA; Holmberg LA; Chen CS; Wener MH; Ryan K; Sunderhaus J; Russell K; Rambharose J; Storb R; Furst DE
    Blood; 2002 Sep; 100(5):1602-10. PubMed ID: 12176878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study.
    Nash RA; McSweeney PA; Crofford LJ; Abidi M; Chen CS; Godwin JD; Gooley TA; Holmberg L; Henstorf G; LeMaistre CF; Mayes MD; McDonagh KT; McLaughlin B; Molitor JA; Nelson JL; Shulman H; Storb R; Viganego F; Wener MH; Seibold JR; Sullivan KM; Furst DE
    Blood; 2007 Aug; 110(4):1388-96. PubMed ID: 17452515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.
    Fassas A; Passweg JR; Anagnostopoulos A; Kazis A; Kozak T; Havrdova E; Carreras E; Graus F; Kashyap A; Openshaw H; Schipperus M; Deconinck E; Mancardi G; Marmont A; Hansz J; Rabusin M; Zuazu Nagore FJ; Besalduch J; Dentamaro T; Fouillard L; Hertenstein B; La Nasa G; Musso M; Papineschi F; Rowe JM; Saccardi R; Steck A; Kappos L; Gratwohl A; Tyndall A; Samijn J;
    J Neurol; 2002 Aug; 249(8):1088-97. PubMed ID: 12195460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.